نتایج جستجو برای: low grade glioma

تعداد نتایج: 1363284  

2016
Ling-Gang Cheng Wen He Hong-Xia Zhang Qian Song Bin Ning Hui-Zhan Li Yan He Song Lin

OBJECTIVE The aim of our study was to investigate the value of intraoperative contrast enhanced ultrasound (CEUS) for evaluating the grade of glioma and the correlation between microvessel density (MVD) and vascular endothelial growth factor (VEGF). METHODS We performed intraoperative conventional ultrasound (CUS) and CEUS on 88 patients with gliomas. All of the patients have undergone surger...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012
Helen Toledano Myriam Ben-Arush Isaac Yaniv

TO THE EDITOR: We read with interest the publication by Ater et al on the comparison between two different chemotherapy regimens for low-grade glioma in children. The primary aim was to compare the event-free survival but the stated secondary aims included a comparison of toxicity of the two regimens. The discussion mentions the fear that the TPCV (thioguanine, procarbazine, CCNU, vincristine) ...

2017
Mohammed Khurshed Remco J. Molenaar Krissie Lenting William P. Leenders Cornelis J.F. van Noorden

Hotspot mutations in isocitrate dehydrogenase 1 (IDH1) initiate low-grade glioma and secondary glioblastoma and induce a neomorphic activity that converts α-ketoglutarate (α-KG) to the oncometabolite D-2-hydroxyglutarate (D-2-HG). It causes metabolic rewiring that is not fully understood. We investigated the effects of IDH1 mutations (IDH1MUT) on expression of genes that encode for metabolic en...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2015
Xing Kang Rong Chen Jie Zhang Gang Li Peng-Gao Dai Chao Chen Hui-Juan Wang

BACKGROUND Zinc transporters have been considered as essential regulators in many cancers; however, their mechanisms remain unknown, especially in gliomas. Isocitrate dehydrogenase 1(IDH1) mutation is crucial to glioma. This study aimed to investigate whether zinc transporters are correlated with glioma grade and IDH1 mutation status. MATERIALS AND METHODS IDH1 mutation status and mRNA expres...

2017
Ling Yang Yongping Mu Hongwei Cui Yabing Liang Xiulan Su

MicroRNAs are short, single-stranded non-coding RNA molecules that function as regulators of tumor progression in various cancers, including glioma. The present study sought to investigate the biological functions of miR-9-3p in glioma progression. The results of a microRNA microarray indicated that microRNA-9-3p (miR-9-3p, miR-9*) is down-regulated in high-grade (grades III and IV) gliomas com...

Journal: :Cell 2016
Michele Ceccarelli Floris P. Barthel Tathiane M. Malta Thais S. Sabedot Sofie R. Salama Bradley A. Murray Olena Morozova Yulia Newton Amie Radenbaugh Stefano M. Pagnotta Samreen Anjum Jiguang Wang Ganiraju Manyam Pietro Zoppoli Shiyun Ling Arjun A. Rao Mia Grifford Andrew D. Cherniack Hailei Zhang Laila Poisson Carlos Gilberto Carlotti Daniela Pretti da Cunha Tirapelli Arvind Rao Tom Mikkelsen Ching C. Lau W. K. Alfred Yung Raul Rabadan Jason Huse Daniel J. Brat Norman L. Lehman Jill S. Barnholtz-Sloan Siyuan Zheng Kenneth Hess Ganesh Rao Matthew Meyerson Rameen Beroukhim Lee Cooper Rehan Akbani Margaret Wrensch David Haussler Kenneth D. Aldape Peter W. Laird David H. Gutmann Houtan Noushmehr Antonio Iavarone Roel G.W. Verhaak

Therapy development for adult diffuse glioma is hindered by incomplete knowledge of somatic glioma driving alterations and suboptimal disease classification. We defined the complete set of genes associated with 1,122 diffuse grade II-III-IV gliomas from The Cancer Genome Atlas and used molecular profiles to improve disease classification, identify molecular correlations, and provide insights in...

Journal: :Neurosurgical focus 2015
Elizabeth B Claus Kyle M Walsh John K Wiencke Annette M Molinaro Joseph L Wiemels Joellen M Schildkraut Melissa L Bondy Mitchel Berger Robert Jenkins Margaret Wrensch

Significant gaps exist in our understanding of the causes and clinical management of glioma. One of the biggest gaps is how best to manage low-grade (World Health Organization [WHO] Grade II) glioma. Low-grade glioma (LGG) is a uniformly fatal disease of young adults (mean age 41 years), with survival averaging approximately 7 years. Although LGG patients have better survival than patients with...

Journal: :Neuro-Chirurgie 2015
Y N Yordanova M-A Rodriguez-Arribas H Duffau

We report on a young woman with a left temporal diffuse low-grade glioma treated initially by a subtotal resection. A focal anaplastic area appeared 5years later and was treated by radiosurgery. A long-time stabilization was therefore obtained and lasted even after pregnancy, which is a known factor of faster tumour progression. This report shows that radiosurgery could be an option in the mult...

2017
Anna F. Delgado Markus Fahlström Markus Nilsson Shala G. Berntsson Maria Zetterling Sylwia Libard Irina Alafuzoff Danielle van Westen Jimmy Lätt Anja Smits Elna-Marie Larsson

BACKGROUND Diffusion kurtosis imaging (DKI) allows for assessment of diffusion influenced by microcellular structures. We analyzed DKI in suspected low-grade gliomas prior to histopathological diagnosis. The aim was to investigate if diffusion parameters in the perilesional normal-appearing white matter (NAWM) differed from contralesional white matter, and to investigate differences between gli...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید